Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting-Reference-Cited by-同舟云学术

Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting

Published:2022-10-09 Issue:6 Volume:32 Page:492-498
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Medicine

Author:

Pandey Hem Chandra¹^ORCID,Varghese Mariamma¹,Rana Arvind¹,Kumar Raj¹,Jain Pankaj¹

Affiliation:

1. Main Blood Bank, Department of Transfusion Medicine All India Institute of Medical Sciences New Delhi India

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.12923

Reference22 articles.

1. A national level estimation of population need for blood in India

2. Blood transfusion: the silent epidemic

3. Cost of treatment and consequences for chronic hepatitis B and C virus infection at a tertiary care hospital in Delhi

4. WHO Expert Committee on Biological Standardization.Guidelines on estimation of residual risk of HIV HBV or HCV infections via cellular blood components and plasma. 2017. WHO. Accessed July 2 2022.https://cdn.who.int/media/docs/default‐source/biologicals/blood‐products/document‐migration/resriskgl_who_trs_1004_web_annex_4.pdf?sfvrsn=55dd09d3_3

5. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus‐1 & hepatitis B & C viruses in Indian blood donors;Makroo RN;Indian J Med Res,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan;Cureus;2023-01-25